SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (572)2/16/1999 7:57:00 AM
From: Russian Bear  Respond to of 1073
 
Rick,

OXGN discontinues development of Neu-Sensamide: biz.yahoo.com

You posted earlier that you were skeptical of subset analysis... It looks like you were right again!

RB



To: scaram(o)uche who wrote (572)2/16/1999 4:13:00 PM
From: freelyhovering  Respond to of 1073
 
Richard--I was not sure which thread to post to you on. Check out CEPH as it has a new narcolepsy drug coming to market at the end of this month. My sleep research friend says it is quite good in trials and may also be used for ADD. Provigil will be the name of the drug. Myron